A collaborative platform for paperless relicensing
A collaborative platform for paperless relicensing
This course equips clinicians to recognise obstructive sleep apnea (OSA) in everyday practice and manage it using evidence-based pathways, covering key symptoms and risk factors, common comorbidities (including cardiometabolic and neurocognitive consequences), appropriate use of screening tools and sleep studies, and practical treatment strategies such as lifestyle measures, PAP therapy optimisation and adherence support, oral appliances, and selected surgical options, supported by real-world case discussions.
| Duration : 01:00:00 hours |
| Content provider : Accrecent |
| Date launched at CMEPEDIA : June 17, 2026 |
| Expiry date of course : Accreditation in progress |
| Module size : 24.99MB |
| Price : ₹1208.29 |
Accrecent requires all individuals in control of educational content to disclose financial relationships with ineligible companies from at least the past 24 months, preferably from the time of their graduation. All relevant relationships from planners, editorial staff, authors, and peer reviewers have been disclosed, reviewed, and appropriately mitigated in accordance with ACCME Standards.
Ineligible companies are defined as organisations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Emma Van Hoecke, the founder of Accrecent, has no relevant financial relationships to disclose.
All other team members of Accrecent involved in the development or review of this content have no relevant financial relationships to disclose.
The financial disclosure status of all authors and peer reviewers is provided in the "Authors & Peer Reviewers" section of this activity.
Define and differentiate the major types of sleep apnea (OSA and CSA)
Explain the pathophysiological mechanisms of OSA
Describe and evaluate the systemic health consequences of untreated OSA, including cardiovascular, metabolic, neurocognitive, and safety-related outcomes.
Apply validated screening tools (STOP-BANG, ESS, Berlin Questionnaire) to identify patients at risk for moderate-to-severe OSA in clinical practice.
Differentiate between diagnostic modalities (PSG and HSAT) and select the most appropriate test based on the patient's profile and resource setting.
Formulate an evidence-based management plan integrating lifestyle changes, PAP therapy, oral appliances, surgical interventions, and strategies to improve adherence.
Dr Sujay Halkur Shankar
MD (Medicine), DM (Pulmonary, Critical Care & Sleep Medicine), MRCP (UK) – Respiratory Medicine, EDARM (Switzerland)
Dr. Sujay is an Associate Consultant Pulmonologist at SPARSH Hospital, Bengaluru. He specialises in respiratory, critical care, and sleep medicine with a clinical focus on obstructive sleep apnea, COPD, asthma, and interstitial lung disease. Trained across leading national and international centres, Dr Shankar brings an evidence-based, patient-centred approach to diagnosis and management, with particular expertise in OSA evaluation, risk stratification, and long-term follow-up. He is committed to advancing clinical practice and education in sleep and respiratory medicine in India.
Dr. Sonali Dabhade
Dr. Sonali Dabhade is an Otorhinolaryngologist (ENT specialist) practising at Ruby Hall Clinic, Pune. With over 14 years of clinical experience, she specialises in the diagnosis and management of ear, nose, and throat disorders, with particular expertise in upper airway conditions and sleep-related breathing disorders.
Dr. Dabhade completed her MBBS and MS (ENT) from Maharashtra University of Health Sciences. Her clinical practice includes the management of nasal obstruction, chronic rhinosinusitis, allergic rhinitis, tonsillar and adenoidal disease, and structural airway abnormalities contributing to obstructive sleep apnea (OSA).
